Evonik Industries (EVK) Given a €39.00 Price Target by Commerzbank Analysts
Evonik Industries (FRA:EVK) has been given a €39.00 ($45.35) price target by research analysts at Commerzbank in a research report issued to clients and investors on Monday. The brokerage currently has a “buy” rating on the stock. Commerzbank’s price target points to a potential upside of 44.18% from the stock’s current price.
EVK has been the topic of several other reports. equinet set a €41.00 ($47.67) price objective on Evonik Industries and gave the stock a “buy” rating in a research note on Tuesday, November 6th. Societe Generale set a €40.00 ($46.51) target price on Evonik Industries and gave the company a “buy” rating in a research note on Monday. Morgan Stanley set a €38.00 ($44.19) target price on Evonik Industries and gave the company a “buy” rating in a research note on Tuesday, July 24th. Deutsche Bank set a €40.00 ($46.51) target price on Evonik Industries and gave the company a “buy” rating in a research note on Tuesday, October 2nd. Finally, UBS Group set a €27.00 ($31.40) target price on Evonik Industries and gave the company a “sell” rating in a research note on Monday, July 16th. Five investment analysts have rated the stock with a sell rating, four have issued a hold rating and thirteen have issued a buy rating to the company. Evonik Industries presently has a consensus rating of “Hold” and a consensus price target of €34.30 ($39.88).
Shares of EVK opened at €27.05 ($31.45) on Monday. Evonik Industries has a 12-month low of €26.78 ($31.14) and a 12-month high of €32.97 ($38.34).
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
Featured Article: Closed-End Mutual Funds (CEFs)
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.